MannKind Corporation [MNKD] Stock trading around $3.12 per share: What’s Next?


MannKind Corporation [NASDAQ: MNKD] stock went on a downward path that fall over -0.95% on Wednesday, amounting to a one-week price decrease of less than -10.34%. The company report on April 27, 2022 that MannKind Presents Poster at 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2022) to Be Held April 27-30.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


Simplified 2x dose of Technosphere® Insulin (TI) produced a statistically significant improvement in PPGE between Dose 1 & 2 from 45-120 minutes.

Higher dose of TI resulted in a mean difference of 52 mg/dL in PPGE at 120 minutes, with no new safety concerns.

Over the last 12 months, MNKD stock dropped by -35.00%. The one-year MannKind Corporation stock forecast points to a potential upside of 48.0. The average equity rating for MNKD stock is currently 1.70, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $822.43 million, with 251.10 million shares outstanding and 237.90 million shares in the current float. Compared to the average trading volume of 3.01M shares, MNKD stock reached a trading volume of 4291190 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on MannKind Corporation [MNKD]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MNKD shares is $6.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MNKD stock is a recommendation set at 1.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

RBC Capital Mkts have made an estimate for MannKind Corporation shares, keeping their opinion on the stock as Sector Perform, with their previous recommendation back on May 14, 2021. While these analysts kept the previous recommendation, Oppenheimer raised their target price to Outperform. The new note on the price target was released on December 24, 2019, representing the official price target for MannKind Corporation stock. Previously, the target price had yet another raise to $3, while Cantor Fitzgerald analysts kept a Overweight rating on MNKD stock.

The Average True Range (ATR) for MannKind Corporation is set at 0.18, with the Price to Sales ratio for MNKD stock in the period of the last 12 months amounting to 10.91.

MNKD Stock Performance Analysis:

MannKind Corporation [MNKD] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -10.34. With this latest performance, MNKD shares dropped by -13.09% in over the last four-week period, additionally sinking by -31.88% over the last 6 months – not to mention a drop of -35.00% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MNKD stock in for the last two-week period is set at 36.11, with the RSI for the last a single of trading hit 28.80, and the three-weeks RSI is set at 40.13 for MannKind Corporation [MNKD]. The present Moving Average for the last 50 days of trading for this stock 3.50, while it was recorded at 3.27 for the last single week of trading, and 4.18 for the last 200 days.

Insight into MannKind Corporation Fundamentals:

MannKind Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.40 and a Current Ratio set at 4.50.


The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MNKD. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for MannKind Corporation go to 35.60%.

MannKind Corporation [MNKD] Insider Position Details

There are presently around $347 million, or 45.20% of MNKD stock, in the hands of institutional investors. The top three institutional holders of MNKD stocks are: BLACKROCK INC. with ownership of 20,993,492, which is approximately -3.115% of the company’s market cap and around 1.60% of the total institutional ownership; STATE STREET CORP, holding 13,048,311 shares of the stock with an approximate value of $41.1 million in MNKD stocks shares; and VANGUARD GROUP INC, currently with $39.83 million in MNKD stock with ownership of nearly 5.54% of the company’s market capitalization.

Positions in MannKind Corporation stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 88 institutional holders increased their position in MannKind Corporation [NASDAQ:MNKD] by around 9,678,564 shares. Additionally, 75 investors decreased positions by around 5,998,183 shares, while 55 investors held positions by with 94,559,788 shares. The mentioned changes placed institutional holdings at 110,236,535 shares, according to the latest SEC report filing. MNKD stock had 33 new institutional investments in for a total of 1,917,023 shares, while 26 institutional investors sold positions of 1,227,120 shares during the same period.